# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Wedbush analyst Laura Chico reiterates Vigil Neuroscience (NASDAQ:VIGL) with a Outperform and maintains $22 price target.
HC Wainwright & Co. analyst Andrew Fein reiterates Vigil Neuroscience (NASDAQ:VIGL) with a Buy and maintains $24 price t...
Vigil Neuroscience (NASDAQ:VIGL) reported quarterly losses of $(0.50) per share which beat the analyst consensus estimate of $(...
JMP Securities analyst Jason Butler reiterates Vigil Neuroscience (NASDAQ:VIGL) with a Market Outperform and maintains $23 p...
JMP Securities analyst Jason Butler reiterates Vigil Neuroscience (NASDAQ:VIGL) with a Market Outperform and maintains $23 p...
- Findings from ILLUMINATE Natural History Study show that MRI and fluid biomarkers are emerging as key measures of ALSP pathop...
HC Wainwright & Co. analyst Andrew Fein maintains Vigil Neuroscience (NASDAQ:VIGL) with a Buy and maintains $24 price ta...